Dodel R - Search Results

1

Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Stamelou M, Cabanel N, Sixel-Döring F, Eggert K, Höglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE. Winter Y, et al. Among authors: dodel r. J Neurol. 2011 Oct;258(10):1827-34. doi: 10.1007/s00415-011-6028-7. Epub 2011 Apr 10. J Neurol. 2011. PMID: 21479850

2

International guide to drugs for Parkinson's disease.

Oertel WH, Dodel RC. Oertel WH, et al. Among authors: dodel rc. Mov Disord. 1995 Mar;10(2):121-31. doi: 10.1002/mds.870100202. Mov Disord. 1995. PMID: 7753054

3

Pallidal lesions. Structural and functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Paulus W, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Arch Neurol. 1996 Jul;53(7):682-6. doi: 10.1001/archneur.1996.00550070124020. Arch Neurol. 1996. PMID: 8929177

4

Activation mapping in essential tremor with functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Ann Neurol. 1997 Jan;41(1):32-40. doi: 10.1002/ana.410410108. Ann Neurol. 1997. PMID: 9005863

5

[Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].

Dodel RC, Singer M, Köhne-Volland R, Selzer R, Scholz W, Rathay B, Oertel WH. Dodel RC, et al. Nervenarzt. 1997 Dec;68(12):978-84. doi: 10.1007/s001150050226. Nervenarzt. 1997. PMID: 9465341 German.

6

Costs of drug treatment in Parkinson's disease.

Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Dodel RC, et al. Mov Disord. 1998 Mar;13(2):249-54. doi: 10.1002/mds.870130209. Mov Disord. 1998. PMID: 9539337

7

Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Dodel RC, Kirchner A, Koehne-Volland R, Künig G, Ceballos-Baumann A, Naumann M, Brashear A, Richter HP, Szucs TD, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 1997 Dec;12(6):695-706. doi: 10.2165/00019053-199712060-00009. Pharmacoeconomics. 1997. PMID: 10175981

8

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Dodel RC, Singer M, Köhne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 1998 Sep;14(3):299-312. doi: 10.2165/00019053-199814030-00006. Pharmacoeconomics. 1998. PMID: 10186468

9

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.

Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmüller F, Müller U, Kurz A, Zimmer R, Evans RM, Hake A, Gasser T, Oertel WH, Griffin WS, Paul SM, Farlow MR. Du Y, et al. Among authors: dodel rc. Neurology. 2000 Aug 22;55(4):480-3. doi: 10.1212/wnl.55.4.480. Neurology. 2000. PMID: 10953177

10

A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease.

Dodel RC, Lohmüller F, Du Y, Eastwood B, Gocke P, Oertel WH, Gasser T. Dodel RC, et al. Neurology. 2001 Apr 10;56(7):982-3. doi: 10.1212/wnl.56.7.982. Neurology. 2001. PMID: 11294947 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters